miR-322 stabilizes MEK1 expression to inhibit RAF/MEK/ERK pathway activation in cartilage
- PMID: 28851708
- DOI: 10.1242/dev.148429
miR-322 stabilizes MEK1 expression to inhibit RAF/MEK/ERK pathway activation in cartilage
Abstract
Cartilage originates from mesenchymal cell condensations that differentiate into chondrocytes of transient growth plate cartilage or permanent cartilage of the articular joint surface and trachea. MicroRNAs fine-tune the activation of entire signaling networks and thereby modulate complex cellular responses, but so far only limited data are available on miRNAs that regulate cartilage development. Here, we characterize a miRNA that promotes the biosynthesis of a key component in the RAF/MEK/ERK pathway in cartilage. Specifically, by transcriptome profiling we identified miR-322 to be upregulated during chondrocyte differentiation. Among the various miR-322 target genes in the RAF/MEK/ERK pathway, only Mek1 was identified as a regulated target in chondrocytes. Surprisingly, an increased concentration of miR-322 stabilizes Mek1 mRNA to raise protein levels and dampen ERK1/2 phosphorylation, while cartilage-specific inactivation of miR322 in mice linked the loss of miR-322 to decreased MEK1 levels and to increased RAF/MEK/ERK pathway activation. Such mice died perinatally due to tracheal growth restriction and respiratory failure. Hence, a single miRNA can stimulate the production of an inhibitory component of a central signaling pathway to impair cartilage development.
Keywords: CRISPR; Cartilage; MAPK; MEK; Stabilization; miR-322.
© 2017. Published by The Company of Biologists Ltd.
Similar articles
-
MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):150-157. doi: 10.26355/eurrev_201801_14112. Eur Rev Med Pharmacol Sci. 2018. Retraction in: Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8240. doi: 10.26355/eurrev_202008_22580 PMID: 29364482 Retracted.
-
Crucial requirement of ERK/MAPK signaling in respiratory tract development.Development. 2014 Aug;141(16):3197-211. doi: 10.1242/dev.110254. Development. 2014. PMID: 25100655
-
ERK1/2 can feedback-regulate cellular MEK1/2 levels.Cell Signal. 2015 Oct;27(10):1939-48. doi: 10.1016/j.cellsig.2015.07.003. Epub 2015 Jul 9. Cell Signal. 2015. PMID: 26163823 Free PMC article.
-
MEK1/2 inhibitors in the treatment of gynecologic malignancies.Gynecol Oncol. 2014 Apr;133(1):128-37. doi: 10.1016/j.ygyno.2014.01.008. Epub 2014 Jan 14. Gynecol Oncol. 2014. PMID: 24434059 Review.
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.Oncogene. 2007 May 14;26(22):3291-310. doi: 10.1038/sj.onc.1210422. Oncogene. 2007. PMID: 17496923 Review.
Cited by
-
PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.Cancers (Basel). 2021 May 6;13(9):2232. doi: 10.3390/cancers13092232. Cancers (Basel). 2021. PMID: 34066486 Free PMC article. Review.
-
Transcriptional, epigenetic and microRNA regulation of growth plate.Bone. 2020 Aug;137:115434. doi: 10.1016/j.bone.2020.115434. Epub 2020 May 16. Bone. 2020. PMID: 32422296 Free PMC article. Review.
-
MiR-322-5p is involved in regulating chondrocyte proliferation and differentiation in offspring's growth plate of maternal gestational diabetes.Sci Rep. 2024 Aug 29;14(1):20136. doi: 10.1038/s41598-024-69523-z. Sci Rep. 2024. PMID: 39209899 Free PMC article.
-
MicroRNAs in cartilage development and dysplasia.Bone. 2020 Nov;140:115564. doi: 10.1016/j.bone.2020.115564. Epub 2020 Jul 31. Bone. 2020. PMID: 32745689 Free PMC article. Review.
-
Metazoan MicroRNAs.Cell. 2018 Mar 22;173(1):20-51. doi: 10.1016/j.cell.2018.03.006. Cell. 2018. PMID: 29570994 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous